Press release
Global Ophthalmology Drugs Market Analysis, Angiogenesis Modulators and Gene Therapies 2022
Researchmoz added Most up-to-date research on "Global Ophthalmology Drugs Market to 2022-Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period" to its huge collection of research reports.Ophthalmology is a therapy area that deals with the diagnosis, treatment and prevention of diseases associated with the eyes and visual system. Most eye disorders occur over a long period of time, and are initially asymptomatic or cause only a slight decrease in vision. However, over time this becomes quite marked. Ophthalmologic disorders cannot currently be cured, and treatment is aimed at managing the disease indication in order to reduce the severity of symptoms and slow progression.
Angiogenesis inhibitors are the most effective and most common therapies used in ophthalmology; this class of compounds has been the most commercially successful in the past decade, with products such as Eylea and Lucentis generating strong annual revenues. Although there are many generics available across the majority of ophthalmology disorders, there are a number of premium products that attract substantial revenues – in particular Eylea, Lucentis, Lumigan and Restasis. The report focuses on five key indications within ophthalmology: glaucoma, age-related macular degeneration (AMD), diabetic macular edema, diabetic retinopathy and dry eye syndrome. There are currently no therapeutic options available for the treatment of dry AMD, increasing the need for extensive R&D within this area.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=799448
Although there is a high degree of failure and uncertainty within the R&D of ophthalmology drugs, the number of drugs in the pipeline is very high, at 734. The majority of pipeline products are novel active pharmaceutical ingredients, with only a small proportion of products being either generics or repositioned from other indications. This shows progression in terms of the variety of different molecules being developed as therapeutic agents within the ophthalmology pipeline. The expected growth of the ophthalmology market over the forecast period is attributed to the approval of new drugs, as well as rising prevalence.
Scope
- Global revenues for the ophthalmology market are forecast to grow at a compound annual growth rate of 9.48%, from $13.7 billion in 2015 to $26 billion in 2022. Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period?
- The ophthalmology pipeline is large and diverse, and contains 734 products. How does the composition of the pipeline compare with that of the existing market?
- What mechanisms of action and molecule types are most commonly being trialed in pipeline products in the various key indications?
- Which products will contribute to market growth most significantly, and which will achieve blockbuster status?
- Will the current market leaders retain their dominance over the forecast period, and how is their revenue share of the dermatology market set to change?
Reasons To Buy
This report will allow you to:
- Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis
- Visualize the composition of the ophthalmology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players
- Analyze the ophthalmology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications
- Understand the growth in patient epidemiology and market revenues for the ophthalmology market, globally and across the key players and product types
- Stratify the market in terms of the split between generic and premium products, and assess the role of these product types in the treatment of the various ophthalmology disorders.
- Identify commercial opportunities in the urological cancer deals landscape by analyzing trends in licensing and co-development deals
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=799448
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Email: sales@researchmoz.us
Website @ http://www.researchmoz.us/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Ophthalmology Drugs Market Analysis, Angiogenesis Modulators and Gene Therapies 2022 here
News-ID: 497053 • Views: …
More Releases from Ophthalmology Drugs Market

Global Ophthalmology Drugs Market to 2023 : Industry Key Insight, Top Vendor Ana …
Researchmoz added Most up-to-date research on "Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape" to its huge collection of research reports. An insight on the important factors and trends influencing the market.
Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such…

Research of Ophthalmology Drugs Market in Global Industry : Trends, Analysis, Gr …
Albany, NY, 5th January : Recent research and the current scenario as well as future market potential of "Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape" globally.
Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such diseases as glaucoma, age-related macular…

Business Strategy in Global Ophthalmology Drugs Industry 2017
Albany, NY, 23rd November : Recent research and the current scenario as well as future market potential of "Global Ophthalmology Drugs Market to 2023 - Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape" globally.
Ophthalmology is a broad therapy area that consists of almost 100 disorders associated with the eyes and visual system, including such diseases as glaucoma, age-related macular…
Global Ophthalmology Drugs Market Growth and Forecast To 2022-Angiogenesis Modul …
Worldwide Market studies the current scenario as well as future market potential of "Global Ophthalmology Drugs Market To 2022-Angiogenesis Modulators And Gene Therapies To Boost Overall Revenue Within The Forecast Period"
Ophthalmology is a therapy area that deals with the diagnosis, treatment and prevention of diseases associated with the eyes and visual system. Most eye disorders occur over a long period of time, and are initially asymptomatic or cause only a…
More Releases for Angiogenesis
Angiogenesis Assay Kit Market Forecasts, Market Trends and Impact Analysis (2024 …
Angiogenesis Assay Kit Market Snapshot: Insight into Market Trends and Movements
An Angiogenesis Assay Kit is a laboratory tool used to measure the formation of new blood vessels from existing ones.
The Angiogenesis Assay Kit market is witnessing significant growth driven by advancements in biomedical research and increasing prevalence of diseases requiring enhanced vascularization, such as cancer and cardiovascular disorders. The rising demand for personalized medicine and targeted therapies bolsters the need…
Angiogenesis Modulators Market Analysis, Size, Current Scenario and Future Prosp …
Angiogenesis Modulators Market was valued at USD Billion in 2023 and is expected to grow at a CAGR of 34% between 2024 and 2031. Vital insights into market growth factors, market trends and market essentials provide in this --Angiogenesis Modulators Market research report greatly help to enhance business performance, avoid future setbacks and fuel long-term strategy. Fueling business performance is one of the important concerns of any newly set business…
Global Angiogenesis Modulators Market, Global Angiogenesis Modulators Industry, …
The Angiogenesis Modulators market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Angiogenesis Modulators Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Angiogenesis Modulators market. The report focuses on well-known providers in the global…
Angiogenesis Assay Market: Competitive Dynamics & Global Outlook 2024
LP INFORMATION offers a latest published report on Angiogenesis Assay Market Analysis and Forecast 2019-2024 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Angiogenesis Assay market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,…
Angiogenesis Assay Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Angiogenesis Assay Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Angiogenesis Assay players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Angiogenesis Assay with respect to individual growth…
Cancer Angiogenesis Inhibitors Market Cancer Angiogenesis Clinical Pipeline Repo …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Angiogenesis: History and Quest for Treatment
2. Angiogenesis Inhibitors: An Ounce of Cure & Prevention
2.1 Hallmarks of Cancer
2.1.1 Self Sufficiency in Growth Signals
2.1.2 Insensitivity to Antigrowth Signals
2.1.3 Acquired Capability: Evading Apoptosis
2.1.4 Limitless Replicative Potential
2.1.5 Sustained Angiogenesis
…